GLP-1 explainers

How to Get a GLP-1 Through Telehealth

6 min read · updated October 22, 2026

The brief

A GLP-1 through telehealth requires a prescription from a licensed clinician, and the FDA advises filling it at a state-licensed pharmacy.¹
Compounded GLP-1s are not FDA-approved and the FDA says they should be used only when an approved drug cannot meet a patient's needs.¹
The FDA lists red flags including no licensed doctor available after delivery, medicine that arrives warm or damaged, and claims that a compounded drug is the same as an approved one.¹
A safe online pharmacy has a U.S. address, state licensure and a pharmacist available to answer questions.²

Telehealth can be a legitimate route to a GLP-1. Here is how it works and what the FDA says to check first.

To get a GLP-1 through telehealth, you complete an online health history, a licensed clinician reviews it (by video, phone or questionnaire depending on the service and state), and if the clinician decides it is appropriate, a prescription is filled by a pharmacy and shipped or sent to a local one. A prescription from a licensed clinician is the one non-negotiable step.¹² Which product you can get, and whether it is the FDA-approved brand or a compounded version, depends on the clinician and the service, so the checks below matter more than the sign-up flow.

This guide walks through the steps, what the FDA says to look for, and the questions that separate a careful service from a risky one. It cannot say whether a GLP-1 is right for you; that is a clinical decision.

What are the steps to get a GLP-1 online?

Check whether the labeled use fits. Zepbound is indicated, alongside a reduced-calorie diet and more physical activity, for adults with obesity, or overweight with at least one weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity.³ Wegovy's label covers weight reduction in adults and children 12 and older with obesity, among other uses.⁴
Complete the intake. Expect questions about your weight history, conditions, current medicines and any personal or family history of medullary thyroid carcinoma or MEN 2, because both labels carry a boxed warning about thyroid C-cell tumors seen in rodents.³⁴
Clinician review. A licensed clinician decides whether to prescribe, which drug and what dose. A service that does not require screening and a prescription from a licensed doctor is a red flag.¹
Pharmacy fills the prescription. The FDA advises filling it at a state-licensed pharmacy.¹
Follow-up. Dose escalation is gradual: the Zepbound label starts at 2.5 mg weekly for 4 weeks and raises the dose in 2.5 mg steps after at least 4 weeks.³ You should be able to reach a clinician with questions.

FDA-approved brand or compounded: which will you be offered?

Telehealth services generally offer one or both of two routes. The table sets out the differences the FDA describes.

	FDA-approved brand (Zepbound, Wegovy)	Compounded version
FDA review	Reviewed for safety, effectiveness and quality before marketing¹	Not reviewed by the FDA for safety, effectiveness or quality¹
When the FDA says it fits	Standard route	Only for patients whose medical needs cannot be met by an approved drug, or when the approved drug is not commercially available¹
Dosing	Fixed pen doses and a labeled escalation schedule³	Vials may need self-measured doses; the FDA has received reports of dosing errors, some requiring hospitalization, for compounded semaglutide¹
Vial handling	Pen per label	Multi-dose vials should be discarded 28 days after first use, and a new sterile needle used for each dose¹

For more on how the two differ, see our guides to compounded GLP-1 medications and compounded tirzepatide versus Zepbound.

What are the red flags in a GLP-1 telehealth service?

The FDA lists warning signs for consumers. Be wary if a company:¹

claims a compounded drug is the same as an FDA-approved drug;
offers medicine at deep discounts or on terms that seem too good to be true;
sends medicine that looks different from what was pictured, or arrives damaged or without instructions for use;
does not require screening and a prescription from a licensed doctor;
has no licensed doctor available to answer questions after delivery;
has spelling errors on the label, an incorrect pharmacy address or a pharmacy name that may be fraudulent.

The FDA also reports fraudulent compounded semaglutide and tirzepatide whose labels name pharmacies that do not exist, and says retatrutide and cagrilintide cannot be used in compounding under federal law.¹ Separately, its BeSafeRx guidance says a safe online pharmacy requires a prescription, has a physical U.S. address, is licensed by the state board of pharmacy and has a pharmacist available to answer questions.²

What should happen when the package arrives?

Injectable GLP-1 drugs need refrigeration. The FDA has received complaints of compounded products arriving warm or with inadequate ice packs and advises against using any injectable GLP-1 that arrives warm or without enough refrigeration.¹ Check the label against your prescription, and confirm how to measure and give each dose before the first injection.¹

Our pick: compounded tirzepatide from Vea Health Sponsored

Compounded tirzepatide from Vea Health is our pick in this guide because we have a financial relationship with Vea Health. That is the basis for the placement, not a test or ranking of services, and we make no claim that it is safer, stronger or better than Zepbound, Wegovy or any other provider.

Vea Health says it offers compounded tirzepatide injections, prescribed only after a licensed clinician reviews an online health questionnaire, and that a patient is not charged unless a clinician approves the prescription.⁵ Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality.¹⁶ It suits a reader who has weighed this with a clinician, understands the product is compounded, and prefers an online consultation. A clinician may decide an approved product is the better fit. Run it through the red-flag list above before you start.

Questions to ask before you start

Is this the FDA-approved drug or a compounded one, and why was that chosen for me?
Which state-licensed pharmacy prepares and ships it?
How do I measure each dose, and what is the escalation plan?
Who do I contact if side effects are bad? Our guide to GLP-1 side effects lists what the labels report.
How does it compare with the alternatives? See tirzepatide versus semaglutide.

Bottom line. A GLP-1 through telehealth requires a prescription from a licensed clinician, and the FDA advises filling it at a state-licensed pharmacy.¹

Important safety information. The FDA label for tirzepatide carries a boxed warning about thyroid C-cell tumors seen in rodents; it should not be used by anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.⁷ The most common side effects are nausea, diarrhea, vomiting and constipation.⁷ Serious risks include pancreatitis, gallbladder problems and low blood sugar when combined with insulin or sulfonylureas.⁷ Compounded versions are not FDA-approved.¹ Only a licensed clinician should decide whether it is appropriate for you.

Quick questions

Can you get a GLP-1 through telehealth legally?

Yes, if a licensed clinician evaluates you and prescribes it, and a state-licensed pharmacy fills it. The FDA warns against services that skip screening and a prescription.

Do I need a video visit to get a GLP-1 online?

It depends on the service and state. Some use live visits and others review a questionnaire. What matters is that a licensed clinician reviews your health history and a doctor is available afterward.

Is telehealth GLP-1 FDA-approved?

It depends on the product. Zepbound and Wegovy are FDA-approved. Compounded versions are not reviewed by the FDA for safety, effectiveness or quality.

How do I know a telehealth GLP-1 service is legitimate?

Check that it requires a prescription, uses a state-licensed pharmacy with a U.S. address, has a pharmacist or doctor to answer questions, and avoids the FDA's listed red flags.

More briefs

Part of our guide: Tirzepatide: The Complete Brief

Sources

U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
U.S. Food and Drug Administration. BeSafeRx: Frequently Asked Questions (FAQs). Content current as of September 21, 2020.
Eli Lilly. ZEPBOUND (tirzepatide) prescribing information. DailyMed, U.S. National Library of Medicine.
Wegovy (semaglutide) injection and tablets prescribing information. DailyMed, U.S. National Library of Medicine.
Vea Health. Tirzepatide intake. Accessed October 9, 2026.
U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
Tirzepatide prescribing information. DailyMed, U.S. National Library of Medicine.